1 800 211 715 – Raffle hotline number

You are currently browsing:

Talzenna bags EU approval for gBRCA-mutated breast cancer

An important milestone in breast cancer treatment has been reached as the European Commission announced the approval of Pfizer’s Talzenna for patients with inherited BRCA-mutated locally advanced or metastatic breast cancer. To learn more about this important approval, click the link below: http://www.pharmatimes.com/news/talzenna_bags_eu_approval_for_gbrca-mutated_breast_cancer_1292259?fbclid=IwAR0vDYAm_zBuOopYI69k2izCEkeU_kHgKbqTKroxOmAG5pmf2l9RZTujRE4

Read More

Irish women with breast cancer invited to take part in new clinical trial at DCU

Irish women with HER2-positive breast cancer are invited to take part in a clinical trial in DCU’s National Institute of Cellular Biotechnology. This trial might yield some interesting results. To find out more information click the link below: https://www.independent.ie/irish-news/health/irish-women-with-breast-cancer-invited-to-take-part-in-new-clinical-trial-at-dcu-38274574.html?fbclid=IwAR36KdChRdF-UgaHldc8zV23mfpru6C6EVYulmixvOJ6e8erO-ozPLcyr8o  

Read More

Promising breast cancer drug could reshape treatment

This is a promising breakthrough – a breast cancer drug with the potential to replace traditional chemotherapy could offer effective treatment to patients who previously had limited options. To find out more about this, click the link below: https://www.bostonherald.com/2019/06/15/promising-breast-cancer-drug-could-reshape-treatment/?fbclid=IwAR0BK45Ax2paXVzJUSQJnZenp6AVBjPRZdfebWjdZZyu6-jOHisGPOF8Iho  

Read More

THE RTE GUIDE’S SPECIAL PINK EDITION

In October 2018, the ‘Pink’ edition of the RTE Guide went on sale in aid of Breast Cancer Ireland. As a result, we are delighted to announce that an amazing €8,300 was raised for Breast Cancer Ireland. We would like to say a huge thank you to the RTE Guide and to all its readers […]

Read More
X